0001225208-24-002042.txt : 20240214 0001225208-24-002042.hdr.sgml : 20240214 20240214162159 ACCESSION NUMBER: 0001225208-24-002042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240212 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fitzgerald Joseph Michael CENTRAL INDEX KEY: 0001484186 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 24638780 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0508 4 2024-02-12 0000885725 BOSTON SCIENTIFIC CORP BSX 0001484186 Fitzgerald Joseph Michael 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP & Group Pres, Cardiology 0 Common Stock 2024-02-12 4 G 0 6000.0000 0.0000 D 184354.0000 D Common Stock 2024-02-12 4 G 0 550.0000 0.0000 A 4894.0000 I By Child Common Stock 67974.0000 I By 401(k) Restricted Stock Units 2024-02-12 4 A 0 13848.0000 0.0000 A 2028-02-12 Common Stock 13848.0000 13848.0000 D Stock Option (Right to Buy) 64.9900 2024-02-12 4 A 0 36509.0000 0.0000 A 2034-02-12 Common Stock 36509.0000 36509.0000 D The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. /s/ Susan Thompson, Attorney-in-Fact 2024-02-14